SMAD3 and endometriosis: The above result suggests that the endometrium of women with endometriosis is not subject to significantly abnormal activation of the SMAD protein cascade, and small changes in SMAD3 mRNA expression are likely to be compensated further down the TGF-β/SMAD signaling pathway, which may, in effect, prevent malignant transformation.